Lettnin, Aline Portantiolo <br/><br/>
Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.  [electronic resource] 

 -  Molecular biology reports  Apr 2019 
 - 1873-1884 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-4978 
<br/><br/><label>Standard No.: </label>10.1007/s11033-019-04639-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--metabolism<br/>ATP-Binding Cassette Transporters--genetics<br/>Arachidonate 5-Lipoxygenase--metabolism<br/>Cell Line, Tumor<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Embryonic Stem Cells--metabolism<br/>Gene Expression<br/>Gene Silencing--physiology<br/>Humans<br/>K562 Cells<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics<br/>Multidrug Resistance-Associated Proteins--metabolism<br/>Neoplastic Stem Cells--metabolism<br/>Octamer Transcription Factor-3--genetics<br/>Phenotype<br/>Pseudogenes<br/>SOXB1 Transcription Factors--metabolism